BD is headquartered in New Jersey but has a significant presence in Durham. The medical technology company said in a statement that buying Parata Systems will advance the company’s strategy to “accelerate innovation in smart, connected care and enable new care settings.”
The all-cash deal will also involve Frazier Healthcare Partners, a private equity firm, according to the statement.
BD noted in the statement that the deal to acquire Parata Systems will give “access to a new $600 million pharmacy automation market segment.” That segment could grow by 10% annually and reach $1.5 billion, the statement indicates.
“BD is a great home for our company, innovative solutions and technology, and Parata’s team members,” said Rob Kill, CEO of Parata Systems in a statement. The company’s revenue in the prior 12 months, ending March 31, 2022 was about $220 million, the statement noted.
DEEP TIES TO TRIANGLE
Parata acquired a Canadian firm in early 2021 and announced an expansion in Durham in 2019 that targeted completion in early 2020. The company was founded in 2001 and the co-founders stepped down from daily operations roles in 2010. The company spun off HAP Innovations in 2015.
BD formed a partnership with a Morrisville-based company in 2020 to develop a COVID-19 rapid test. The company has a corporate R&D and technology center in Research Triangle Park and also other facilities in Durham and Mebane. BD is among the companies mentioned in a recent WRAL.com publication that investigates North Carolina’s dominance in clinical research and diagnostic testing. BD also announced a distribution facility to be based in Wilson in 2010 in an economic development project expected at the time to add 180 jobs.
Original Article Source: WRAL TechWire